Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 278

1.

Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study.

Erichsen R, Horvath-Puho E, Lund JL, Dellon ES, Shaheen NJ, Pedersen L, Davey Smith G, Sørensen HT.

Aliment Pharmacol Ther. 2017 Jan 31. doi: 10.1111/apt.13962. [Epub ahead of print]

PMID:
28139003
2.

Barrett's Esophagus: Diagnosis and Management.

Eluri S, Shaheen NJ.

Gastrointest Endosc. 2017 Jan 18. pii: S0016-5107(17)30024-X. doi: 10.1016/j.gie.2017.01.007. [Epub ahead of print] Review. No abstract available.

PMID:
28109913
3.

Impact of Radiofrequency Ablation Treatment of Barrett's Esophagus on Esophageal Adenocarcinoma: A Comparative Modeling Analysis.

Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C.

Clin Gastroenterol Hepatol. 2017 Jan 12. pii: S1542-3565(17)30019-8. doi: 10.1016/j.cgh.2016.12.034. [Epub ahead of print] No abstract available.

PMID:
28089850
4.

Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.

Duits LC, van der Wel MJ, Cotton CC, Phoa KN, Ten Kate FJ, Seldenrijk CA, Offerhaus GJ, Visser M, Meijer SL, Mallant-Hent RC, Krishnadath KK, Pouw RE, Tijssen JG, Shaheen NJ, Bergman JJ.

Gastroenterology. 2016 Dec 22. pii: S0016-5085(16)35506-8. doi: 10.1053/j.gastro.2016.12.008. [Epub ahead of print]

PMID:
28012849
5.

Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.

Cotton CC, Erim D, Eluri S, Palmer SH, Green DJ, Wolf WA, Runge TM, Wheeler S, Shaheen NJ, Dellon ES.

Clin Gastroenterol Hepatol. 2016 Dec 7. pii: S1542-3565(16)31138-7. doi: 10.1016/j.cgh.2016.11.032. [Epub ahead of print]

PMID:
27940272
6.

An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.

Murphy CC, Claire Yang Y, Shaheen NJ, Hofstetter WL, Sandler RS.

Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12526. [Epub ahead of print]

PMID:
27862652
7.

Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.

Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA.

Am J Gastroenterol. 2016 Nov;111(11):1528-1535. doi: 10.1038/ajg.2016.348.

PMID:
27575711
8.

Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis.

Wolf WA, Piazza NA, Gebhart JH, Rusin S, Covey S, Higgins LL, Beitia R, Speck O, Woodward K, Cotton CC, Runge TM, Eluri S, Woosley JT, Shaheen NJ, Dellon ES.

Dig Dis Sci. 2017 Jan;62(1):143-149. doi: 10.1007/s10620-016-4357-1.

PMID:
27778205
9.

Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium.

Runge TM, Shaheen NJ, Djukic Z, Hallquist S, Orlando RC.

Dig Dis Sci. 2016 Nov;61(11):3169-3175.

10.

Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.

Guthikonda A, Cotton CC, Madanick RD, Spacek MB, Moist SE, Ferrell K, Dellon ES, Shaheen NJ.

Am J Gastroenterol. 2017 Jan;112(1):87-94. doi: 10.1038/ajg.2016.451.

PMID:
27725648
11.

Causes and Outcomes of Esophageal Perforation in Eosinophilic Esophagitis.

Runge TM, Eluri S, Cotton CC, Burk CM, Woosley JT, Shaheen NJ, Dellon ES.

J Clin Gastroenterol. 2016 Sep 27. [Epub ahead of print]

PMID:
27680593
12.

Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.

Reed CC, Shaheen NJ.

J Laparoendosc Adv Surg Tech A. 2016 Oct;26(10):768-772.

PMID:
27541732
13.

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.

Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM; Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).; Esophageal Adenocarcinoma GenEtics Consortium (EAGLE).; Wellcome Trust Case Control Consortium 2 (WTCCC2)., Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RG, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WH, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J.

Lancet Oncol. 2016 Oct;17(10):1363-1373. doi: 10.1016/S1470-2045(16)30240-6.

14.

RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.

Blum AE, Venkitachalam S, Guo Y, Kieber-Emmons AM, Ravi L, Chandar AK, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Barnholtz-Sloan JS, Markowitz SD, Willis JE, Shyr Y, Chak A, Varadan V, Guda K.

Cancer Res. 2016 Oct 1;76(19):5628-5633.

PMID:
27503924
15.

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.

Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Gharahkhani P, Palles C, Lagergren J, Fitzgerald RC, Ye W, Caldas C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah PD, Liu G, Iyer P, Corley DA, Risch HA, Chow WH, Prenen H, Chegwidden L, Love S, Attwood S, Moayyedi P, MacDonald D, Harrison R, Watson P, Barr H, deCaestecker J, Tomlinson I, Jankowski J, Whiteman DC, MacGregor S, Vaughan TL, Madeleine MM.

Gut. 2016 Aug 2. pii: gutjnl-2016-311622. doi: 10.1136/gutjnl-2016-311622. [Epub ahead of print]

PMID:
27486097
16.

Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas.

Sun X, Elston R, Falk GW, Grady WM, Faulx A, Mittal SK, Canto MI, Shaheen NJ, Wang JS, Iyer PG, Abrams JA, Willis JE, Guda K, Markowitz S, Barnholtz-Sloan JS, Chandar A, Brock W, Chak A.

Mol Genet Genomic Med. 2016 Mar 14;4(4):407-19. doi: 10.1002/mgg3.211.

17.

Corrigendum: ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Shaheen NJ, Falk GW, Iyer PG, Gerson LB.

Am J Gastroenterol. 2016 Jul;111(7):1077. doi: 10.1038/ajg.2016.186. No abstract available.

PMID:
27356842
18.

Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.

Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2016 Oct;14(10):1412-1419.e3. doi: 10.1016/j.cgh.2016.05.032.

PMID:
27264393
19.

Response to Braillon et al.

Shaheen NJ.

Am J Gastroenterol. 2016 Jun;111(6):900. doi: 10.1038/ajg.2016.131. No abstract available.

PMID:
27249989
20.

Buried Barrett's Esophagus-a Sheep in Sheep's Clothing.

Shafa S, Shaheen NJ.

J Gastrointest Surg. 2016 Jul;20(7):1281-3. doi: 10.1007/s11605-016-3165-4. No abstract available.

PMID:
27184674
Items per page

Supplemental Content

Loading ...
Support Center